Travere Therapeutics, Inc. (TVTX)
34.37
-0.14
(-0.41%)
USD |
NASDAQ |
Dec 10, 16:00
34.38
+0.01
(+0.03%)
After-Hours: 20:00
Travere Therapeutics Profit Margin (Quarterly): 15.59% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | -14.54% |
| Edwards Lifesciences Corp. | 18.82% |
| Intuitive Surgical, Inc. | 28.31% |
| Stryker Corp. | 14.18% |
| iRhythm Technologies, Inc. | -2.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -263.9% |
| Return on Assets | -16.15% |
| Return on Invested Capital | -21.07% |
| Gross Profit Margin (Quarterly) | 89.46% |
| Operating Margin (Quarterly) | 15.12% |
| Return on Net Operating Assets | -51.86% |